Cyclis Pharmaceuticals Inc. discovers and develops novel small molecule drugs for treatment of cancer
Cyclis is researching and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.